Table 2.
Sensitivity of compared assays at 50, 100 and 150 days from symptom onset.
Survival probability (95% CI) | |||
---|---|---|---|
50-day | 100-day | 150-day | |
Abbott-N | 0.985 (0.97;0.99) | 0.919 (0.89;0.95) | 0.655 (0.6;0.71) |
Roche-N | 0.988 (0.98;1.0) | 0.963 (0.94;0.98) | 0.949 (0.92;0.97) |
Roche-S | 0.991 (0.98;1.0) | 0.966 (0.95;0.99) | 0.952 (0.93;0.98) |
MSD | |||
N | 0.988 (0.98;1.0) | 0.972 (0.95;0.99) | 0.907 (0.87;0.94) |
S | 0.997 (0.99;1.0) | 0.978 (0.96;0.99) | 0.968 (0.95;0.99) |
RBD | 0.994 (0.99;1.0) | 0.969 (0.95;0.99) | 0.909 (0.88;0.94) |